Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Point and Redwood Trust Issue $139 Million Home Equity Investment Rated Securitization
-
Fortinet (FTNT) plunges 23% on lowered full-year guidance; Prompts several downgrades
-
Form 8-K Cantor Fitzgerald Income For: Nov 02
-
Cantor Fitzgerald and Harbor Group International Expand Relationship with Joint Venture to Acquire Westchester Multifamily Community
-
Cantor Fitzgerald Starts VinFast Auto Ltd. (VFS) at Overweight, 'good entry-point'
-
Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
-
Cantor Fitzgerald Upgrades Pacific Biosciences of California (PACB) to Overweight, 'attractive entry point'
-
Sarepta Therapeutics crushed after EMBARK misses primary endpoint, prompting 2 downgrades
-
DIF Capital Partners and EDF Invest to acquire leading Norwegian electric ferry operator Fjord1 from Vision Ridge Partners and Havila Holding
-
Zynex (ZYXI) Initiates Review of Strategic Alternatives
-
Zynex Announces Review of Strategic Alternatives
-
Cantor Fitzgerald upgrades Rivian (RIVN) to Overweight following recent pullback
-
Maverick Natural Resources closes $640 million asset-backed securitization
-
After-hours stock movers: Intel jumps on beat, Enphase siks
-
Cantor Fitzgerald Upgrades Rivian Automotive Inc (RIVN) to Overweight, 'We Expect Strong Demand to Continue into 2024'
-
Orchid Island Capital Announces Third Quarter 2023 Results
-
Theratechnologies (THTX) Prices $25M Share Offering at $1/sh
-
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
-
Theratechnologies (THTX) Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
-
Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
-
Form 424B3 Cantor Fitzgerald Income
-
Denison Completes US$55 Million Offering to Fund Long-Lead Procurement for Phoenix ISR Project
-
View, Inc. (VIEW) Announces $50 Million Financing with Strategic Real Estate Investors
-
View Announces $50 Million Financing with Strategic Real Estate Investors
-
Cantor Fitzgerald Starts Genius Sports Ltd. (GENI) at Overweight, 'will deliver robust growth over the coming years'
-
Orchid Island Capital Announces Estimated Third Quarter 2023 Results, October 2023 Monthly Dividend and September 30, 2023 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Infrastructure Fund Announces Third Quarter 2023 Distribution
-
Denison Mines (DNN) Announces $55 Million Bought Deal Offering
-
Denison Announces US$55 Million Bought Deal Offering
-
ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Akero Therapeutics (AKRO) declines after efruxifermin NASH trial readout disappoints; Is it time to buy?
-
Pacira BioSciences (PCRX) Appoints Marcelo Bigal, Abraham Ceesay, Michael Yang, and Alethia Young to its Board
-
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
-
Cantor Fitzgerald on Akero Therapeutics (AKRO), 'we expect the stock to trade down'
-
Fannie Mae Prices $536 Million Connecticut Avenue Securities (CAS) REMIC Deal
-
Borqs Technologies Shortlists Buyers for the Second Round of Due Diligence & Negotiations for the Divestment of Holu Hou Energy LLC
-
Borqs Technologies Shortlists Buyers for the Second Round of Due Diligence & Negotiations for the Divestment of Holu Hou Energy LLC
-
Aston Bay Holdings Ltd. Closes Private Placement
-
Form ARS Cantor Fitzgerald Income For: Dec 31
-
Form DEF 14A Cantor Fitzgerald Income For: Dec 05
-
ALX Oncology (ALXO) Prices 7.37M Share Offering at $6.38/sh
-
ALX Oncology Announces Pricing of Public Offering
-
ALX Oncology (ALXO) Announces Proposed Public Offering of Common Stock, Warrants
-
ALX Oncology Announces Proposed Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Sep 29
-
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
-
Clear Street Appoints Steve Bisgay as Chief Financial Officer
-
Wedbush Securities Initiates Coverage of the U.S. REIT Industry and Welcomes Richard Anderson as Managing Director, Equity Research, and Jay Kornreich as Vice President, Equity Research
-
Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Opti
-
IPA Elects New Board Members and Appoints Fidelity's Bill Duffy as Chair-Elect for 2024

